Neuronal Ferroptosis Attenuation by RKIP Inhibition Following Spontaneous Intracerebral Hemorrhage via NRF2/HO-1...

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Raf kinase inhibitor protein (RKIP) is involved in crucial cellular processes like apoptosis and cell differentiation.
• Neuronal ferroptosis, a regulated cell death pathway, plays a role in brain injury, including intracerebral hemorrhage (ICH).

Purpose of the Study:

• To investigate the role of RKIP in neuronal ferroptosis following ICH.
• To elucidate the underlying mechanisms of RKIP's function in ICH-induced ferroptosis.

Main Methods:

• A cellular model of ICH using cultured rat pheochromocytoma (PC12) cells stimulated with hemin was established.
• Assessed cell viability, RNA and protein expression, reactive oxygen species (ROS), and lipid hydroperoxide (LPO) levels.
• Measured the impact of RKIP inhibition on ferroptosis-related proteins (GPX4, ACSL4) and the NRF2/HO-1 pathway.

Main Results:

• RKIP inhibition demonstrated significant neuroprotection in vitro following ICH.
• Inhibition of RKIP led to increased glutathione peroxidase 4 (GPX4) and decreased acyl-CoA synthetase long-chain family 4 (ACSL4) expression.
• RKIP inhibition reduced ROS and LPO levels, indicating decreased ferroptosis.

Conclusions:

• RKIP inhibition exerts a protective effect against neuronal ferroptosis in vitro after ICH.
• This neuroprotection is potentially mediated by the activation of the nuclear factor E2-related factor 2/heme oxygenase-1 (NRF2/HO-1) pathway.
• Targeting RKIP may represent a novel therapeutic strategy for managing neuronal ferroptosis in ICH.